A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Gaucher Disease

Interventions

DRUG

eliglustat

"Pharmaceutical form: capsule~Route of administration: oral"

Trial Locations (3)

Investigational Site Number 840004, Miami

Investigational Site Number 840001, Knoxville

Investigational Site Number 840002, Saint Paul